Daypro and Keloids - a phase IV clinical study of FDA data
We study 3,839 people who take Daypro or have Keloids. No report of Keloids is found in people who take Daypro.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Daypro?
Daypro has active ingredients of oxaprozin. It is often used in osteoarthritis. eHealthMe is studying from 2,834 Daypro users for its effectiveness, alternative drugs and more.
What is Keloids?
Keloids (overgrown scars left from skin injuries) is found to be associated with 614 drugs and 430 conditions by eHealthMe.
Do you take Daypro and have Keloids?Check whether Keloids is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Keloids and when was it recovered:
Expand to all the drugs that have ingredients of oxaprozin:
Alternative drugs to, pros and cons of Daypro:
- Daypro (2,834 reports)
Keloids treatments and more:
- Keloids (1,005 reports)
COVID vaccines that are related to Keloids:
- Keloids in Moderna COVID Vaccine
- Keloids in Pfizer BioNTech Covid Vaccine
- Keloids in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Keloids:
All the conditions that are associated with Keloids:
How the study uses the data?
The study uses data from the FDA. It is based on oxaprozin (the active ingredients of Daypro) and Daypro (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Wellbutrin and Novolin N drug interaction - 9 seconds ago
- Ativan and Ferrous Fumarate drug interaction - 19 seconds ago
- Benzonatate and Xofluza drug interaction - 19 seconds ago
- Epivir vs. Stribild - 26 seconds ago
- Zestoretic and Colace drug interaction - 35 seconds ago
- Carbamazepine and Amisulpride drug interaction - 35 seconds ago
- Levemir vs. Metformin - 42 seconds ago
- Detrol La and Prempro drug interaction - 47 seconds ago
- Isosorbide Dinitrate and Organ Failure - 49 seconds ago
- Cholestyramine vs. Xifaxan - 50 seconds ago